In vivo, Sema3A overexpression increases CD11b+F4/80+ Mφs accumulation but not CD11b+Ly6C+ monocytic cells, and reduces 4T1-3A+ tumor growth in immune complete BALB/c mice. Here, ITGAM is linked to neoplasm.